Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bioscience
GlaxoSmithKline Appoints Zhi Hong to Head Infectious-Diseases Research Center
April 11th, 2007
GlaxoSmithKline announces the appointment of Zhi Hong, Ph.D., to lead a newly organized research unit dedicated to discovering therapies for infectious diseases, effective 23 April. Currently, Dr. Hong is Executive Vice President and Chief Scientific Officer of Ardea Biosciences, Inc., a San Diego, California, biopharmaceutical company focused on the discovery and development of targeted small molecule drugs to treat viral diseases, cancer, and inflammation. He earlier served as Vice President and Head of Research at Valeant Pharmaceuticals International, where he built up the Discovery group to eventually lead the entire Research group of approximately 120 staff to...
Source: Medical Patent Law Weekly (2007-04-11)
|
